| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 20,27% | 34,12% | 57,37% | · |
| JPM EMERGING MARKETS EQUITY I (ACC) USD | RVI EMERGENTES | 20,27% | 30,82% | 7,48% | 103,42% |
| UBS EURO STOXX 50 ESG UCITS ETF EUR DIS | RV EURO | 20,27% | 50,55% | 74,47% | · |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES I ACC USD | RVI EMERGENTES | 20,26% | 45,79% | 39,53% | 140,07% |
| BNP PARIBAS EUROPE SMALL CAP PRIVILEGE CAP | RVI EUROPA SMALL/MID CAP | 20,25% | 38,69% | 32,54% | 67,68% |
| GOLDMAN SACHS ALL CHINA EQUITY PORTFOLIO P USD CAP | RVI CHINA | 20,24% | 18,32% | -21,70% | 43,88% |
| GVCGAESCO MULTINACIONAL, FI A | RVI GLOBAL | 20,24% | 52,33% | 87,00% | 87,08% |
| NOMURA FUNDS IRELAND - AMERICAN CENTURY EMERGING MARKETS EQUITY FUND I USD | RVI EMERGENTES | 20,24% | 43,25% | 17,63% | · |
| UBS CORE MSCI EMU UCITS ETF HCHF ACC | RV EURO | 20,23% | 50,41% | 86,07% | · |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY I EUR | RVI EMERGENTES | 20,22% | 53,05% | · | 126,44% |
